Prescription Drugs
Filters
Voriconazole (Pinapu) 50/200mg | Beijing Genetech Generic | GLT
Pinapu voriconazole generic 50mg & 200mg x 10 tablets by Beijing Genetech, NMPA-approved triazole antifungal.
Voriconazole (Aike Likang) 50/200mg | Zhejiang Huahai Generic | GLT
Aike Likang voriconazole generic 50mg & 0.2g x 10 tablets by Zhejiang Huahai, NMPA-approved triazole...
Voriconazole (Lailikang) 200mg | Chengdu Huashen Generic | GLT
Lailikang voriconazole generic 200mg x 6 tablets by Chengdu Huashen, NMPA-approved triazole antifungal.
Voriconazole (Lanli) 50mg | Hubei Wushi Generic | GLT
Lanli voriconazole generic 50mg x 24 tablets by Hubei Wushi, NMPA-approved triazole antifungal for weight-based...
Voriconazole (Fujin) 50/200mg | Jincheng Haisi Generic | GLT
Fujin voriconazole generic 50mg & 200mg x 10 tablets by Jincheng Haisi, NMPA-approved triazole antifungal.
Voriconazole (Jinrui Rui Laikang) 50mg | Hainan Jinrui Generic | GLT
Jinrui Rui Laikang voriconazole generic 50mg x 10 tablets by Hainan Jinrui, NMPA-approved triazole antifungal.
Voriconazole (Liwei) 50/200mg | Beijing SL Generic | GLT
Liwei voriconazole generic 50mg x 12 & 200mg x 8 tablets by Beijing SL Pharmaceutical,...
Rapamune (Sirolimus) 1mg Tablets | mTOR Inhibitor | GLT
Pfizer originator sirolimus for kidney transplant rejection and LAM
Ribociclib (Kisqali) 200mg*21's | Novartis Taiwan, China | GLT
Novartis originator Kisqali (ribociclib) 200mg 21 tablets for HR+/HER2- breast cancer, Taiwan-sourced.
Yixinke (Sirolimus) 0.5mg Tablets | China Generic | GLT
North China Pharmaceutical domestic sirolimus for kidney transplant rejection
Ribociclib (Kisqali) 200mg*63's | Novartis China-Sourced | GLT
China-sourced Novartis Kisqali (ribociclib) 200mg 63 tablets, NMPA-approved & reimbursed for HR+/HER2- breast cancer.
Erbitux (Cetuximab) 100mg/500mg Injection | EGFR Inhibitor | GLT
German Merck KGaA originator cetuximab for RAS wild-type mCRC and SCCHN
Enlituo (Cetuximab β) 100mg Injection | China Anti-EGFR mAb | GLT
Taizhou Mabtech improved biologic cetuximab β for RAS/BRAF wild-type mCRC
Datailai (Cetuximab N01) 100mg Injection | China Biosimilar | GLT
Sichuan Kelun-Biotech biosimilar cetuximab N01 for RAS wild-type mCRC
Lazertinib (Lazcluze) 80mg | Janssen China Originator | GLT
NMPA-approved Lazcluze 利珂 (lazertinib) 80mg x 90 tablets by Xi'an Janssen, third-generation EGFR-TKI originator, China-sourced.
Jingruipin (Bosentan) 125mg*30's | China-Made Endothelin Receptor Antagonist | GLT
First domestic Chinese bosentan by Beijing Sihuan Kebao, consistency-evaluated
Tracleer (Bosentan) 125mg*56's | China-Sourced Endothelin Receptor Antagonist | GLT
Actelion bosentan (全可利), NMPA-approved and reimbursed in China-Mainland
Nivolumab (Opdivo) 40/100/120mg | BMS China Originator | GLT
BMS originator Opdivo (nivolumab) 40mg/4mL, 100mg/10mL & 120mg/12mL vials, China-sourced, PD-1 inhibitor for multiple cancers.
Nivolumab (Nivamo) 40mg/4mL | Ziska Bangladesh Biosimilar | GLT
Nivamo — Ziska Pharmaceuticals nivolumab biosimilar 40mg/4mL vial for PD-1 checkpoint cancer therapy.
Nivolumab (Opdyta) 100mg/10mL | BMS India Originator | GLT
BMS India-market originator Opdyta (nivolumab) 100mg/10mL vial, the same PD-1 inhibitor sold as Opdivo worldwide.
Sort
- Recommended
- Price: Low to High
- Price: High to Low
- Newest
- Best Selling